Javascript must be enabled to continue!
Relationship between cerebral amyloid angiopathy and plasma homocysteine levels in Alzheimer’s disease
View through CrossRef
AbstractBackgroundCerebral amyloid angiopathy (CAA) is the characteristic vascular pathology in Alzheimer’s disease (AD). The vascular changes including CAA contribute to mental decline in AD. Elevated plasma total homocysteine (tHcy) is reported to be an independent risk factor for Alzheimer’s disease (AD). Elevated tHcy is also reported to result in CAA in mice. Here we investigated the relationship between CAA and plasma tHcy levels in AD.MethodThe subjects of this study consisted of clinically diagnosed 136 patients with AD (83 females, 53 males, age 75.2±8.8 years). The cortical microbleeds shown by T2*‐weighted MRI images could be CAA‐related. We divided the AD patients into two groups; CAA(+) (AD with CAA, n=46) and CAA(‐) (AD without CAA, n=90). We compared the levels of plasma tHcy between the two groups: CAA(+) and CAA(‐). We also compared CSF biomarkers (tau, ptau‐181 and Abeta42) and MMSE scores between the two groups. The CSF samples were obtained by lumbar puncture after informed consent was obtained. The CSF levels of tau, ptau‐181 and Abeta42 were measured by ELISA (Fujirebio, Belgium) according to the manufacturer’s protocol.ResultThe tHcy levels were 14.3±10.5 nmol/ml in the CAA(+) group and 11.6±4.0 in the CAA(‐) group. The tHct levels showed no significant difference between the two groups. The CSF Abeta42 levels were significantly lower in the CAA(+) group (274.2±108.7 pg/ml) than those in the CAA(‐) group (316.8±112.1 pg/ml, p<0.05, t‐test), whereas the CSF tau and ptau levels showed no difference between the two groups. MMSE scores were lower in the CAA(+) group (16.5±7.0) than those in the CAA(‐) group (20.3±6.3) (p<0.005, t‐test). The tHcy levels were not related to any of CSF biomarkers (tau, ptau‐181 or Abeta42) .ConclusionPlasma tHct levels showed no significant difference between the two groups: CAA(+) and CAA(‐).CSF levels of Abeta42 and MMSE scores were lower in the CAA(+) group than those in the CAA(‐) group.
Title: Relationship between cerebral amyloid angiopathy and plasma homocysteine levels in Alzheimer’s disease
Description:
AbstractBackgroundCerebral amyloid angiopathy (CAA) is the characteristic vascular pathology in Alzheimer’s disease (AD).
The vascular changes including CAA contribute to mental decline in AD.
Elevated plasma total homocysteine (tHcy) is reported to be an independent risk factor for Alzheimer’s disease (AD).
Elevated tHcy is also reported to result in CAA in mice.
Here we investigated the relationship between CAA and plasma tHcy levels in AD.
MethodThe subjects of this study consisted of clinically diagnosed 136 patients with AD (83 females, 53 males, age 75.
2±8.
8 years).
The cortical microbleeds shown by T2*‐weighted MRI images could be CAA‐related.
We divided the AD patients into two groups; CAA(+) (AD with CAA, n=46) and CAA(‐) (AD without CAA, n=90).
We compared the levels of plasma tHcy between the two groups: CAA(+) and CAA(‐).
We also compared CSF biomarkers (tau, ptau‐181 and Abeta42) and MMSE scores between the two groups.
The CSF samples were obtained by lumbar puncture after informed consent was obtained.
The CSF levels of tau, ptau‐181 and Abeta42 were measured by ELISA (Fujirebio, Belgium) according to the manufacturer’s protocol.
ResultThe tHcy levels were 14.
3±10.
5 nmol/ml in the CAA(+) group and 11.
6±4.
0 in the CAA(‐) group.
The tHct levels showed no significant difference between the two groups.
The CSF Abeta42 levels were significantly lower in the CAA(+) group (274.
2±108.
7 pg/ml) than those in the CAA(‐) group (316.
8±112.
1 pg/ml, p<0.
05, t‐test), whereas the CSF tau and ptau levels showed no difference between the two groups.
MMSE scores were lower in the CAA(+) group (16.
5±7.
0) than those in the CAA(‐) group (20.
3±6.
3) (p<0.
005, t‐test).
The tHcy levels were not related to any of CSF biomarkers (tau, ptau‐181 or Abeta42) .
ConclusionPlasma tHct levels showed no significant difference between the two groups: CAA(+) and CAA(‐).
CSF levels of Abeta42 and MMSE scores were lower in the CAA(+) group than those in the CAA(‐) group.
Related Results
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
Objectives
To detect the effect of Sini Decoction on the expression of Sirt-1 and eNOS in EAhy926 cell injured by homocysteine.
...
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
ATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
AbstractUnder the ATN framework, cerebrospinal fluid analytes provide evidence of the presence or absence of Alzheimer’s disease pathological hallmarks: amyloid plaques (A), phosph...
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
Objectives
To detect the effect of Sini Decoction on the expression of Caveolin-1 and eNOS in EAhy926 cell injured by homocysteine.
...
Homocysteine Metabolism in Pregnancy and Developmental Impacts
Homocysteine Metabolism in Pregnancy and Developmental Impacts
Homocysteine is a metabolite generated by methionine cycle metabolism, comprising the demethylated derivative of methionine. Homocysteine can be metabolised by the transsulphuratio...
Assessment of Homocysteine level in H.pylori infected Sudanese Patients
Assessment of Homocysteine level in H.pylori infected Sudanese Patients
The body turns back homocysteine into methionine with the help of vitamin B12. H.pylori induced -gastritis impairs folate and vitamin B12 absorption leading to B12 deficiency. Con...
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
Abstract
Early detection of Alzheimer’s disease is vital for timely treatment. Existing biomarkers for Alzheimer’s disease reflect amyloid- and tau-related pathology...
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
Magnetohydrodynamics enhanced radio blackout mitigation system for spacecraft during planetary entries
(English) Spacecraft entering planetary atmospheres are enveloped by a plasma layer with high levels of ionization, caused by the extreme temperatures in the shock layer. The charg...
Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
Reasons for undergoing amyloid imaging among cognitively unimpaired older adults
AbstractObjectivesPreclinical Alzheimer’s disease (AD) clinical trials screen cognitively unimpaired older adults for biomarker criteria and disclose their results. We examined whe...

